Adam Sander Bertelsen
Professor
Department of Immunology and Microbiology, University of Copenhagen, Denmark
Biography
Adam Sander Bertelsen is professor at the Department of Immunology and Microbiology at the University of Copenhagen and co-founder of the Danish biotech company AdaptVac. With a background in virology, immunology, and vaccine development, he explores how to train the immune system more effectively—using advanced technologies like mRNA and virus-like particles (VLPs). These particles mimic real viruses without causing disease and can be encoded via mRNA to trigger stronger, longer-lasting immune responses. His research played a key role in building Denmark’s vaccine capacity during the COVID-19 pandemic and continues to push the boundaries of how vaccines are designed, produced, and delivered. Bertelsen combines academic research with biotech innovation, transforming molecular insights into real-world tools to fight both emerging infections and global health challenges.
